Estrogen and COVID-19: friend or foe?
作者信息
Di Vincenzo A, Andrisani A, Vettor R, Rossato M
机构信息
Clinica Medica 3, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.
Unit of Gynecology and Obstetrics, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
出版信息
Ann Oncol. 2021 Jul;32(7):933-934. doi: 10.1016/j.annonc.2021.03.201. Epub 2021 Mar 29.
Abstract
摘要
相似文献
1
Estrogen and COVID-19: friend or foe?雌激素与新型冠状病毒肺炎：是友还是敌？
Ann Oncol. 2021 Jul;32(7):933-934. doi: 10.1016/j.annonc.2021.03.201. Epub 2021 Mar 29.
2
Azithromycin in patients with COVID-19: Friend or foe?阿奇霉素用于新冠肺炎患者：是友还是敌？
Clin Microbiol Infect. 2021 Jan;27(1):136-137. doi: 10.1016/j.cmi.2020.09.047. Epub 2020 Sep 29.
3
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy.接受抗雌激素治疗的乳腺癌和卵巢癌患者感染新型冠状病毒2的临床结局
Ann Oncol. 2021 May;32(5):676-677. doi: 10.1016/j.annonc.2021.01.069. Epub 2021 Jan 29.
4
Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.雌激素调节分化气道上皮细胞中 SARS-CoV-2 受体 ACE2 的表达。
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1280-L1281. doi: 10.1152/ajplung.00153.2020. Epub 2020 May 20.
5
Epinephrine use in COVID-19: friend or foe?新冠疫情中肾上腺素的使用：是福是祸？
Eur J Hosp Pharm. 2021 Jan;28(1):e1. doi: 10.1136/ejhpharm-2020-002295. Epub 2020 May 29.
6
SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?2019冠状病毒病疫情期间的钠-葡萄糖协同转运蛋白2抑制：是福是祸？
Diabetes Metab. 2020 Oct;46(5):343-344. doi: 10.1016/j.diabet.2020.06.003. Epub 2020 Jun 17.
7
Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo .2019冠状病毒病期间的非甾体抗炎治疗：是友是敌？对乔洛的《2019冠状病毒病（COVID-19）与非甾体抗炎药（NSAID）》的回应
Ann Rheum Dis. 2021 Feb;80(2):e13. doi: 10.1136/annrheumdis-2020-217638. Epub 2020 Apr 30.
8
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend?皮质类固醇在SARS-CoV-2感染中的应用：是敌，还是能成为友？
Pol Arch Intern Med. 2020 Oct 29;130(10):922. doi: 10.20452/pamw.15661.
9
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply.SARS-CoV-2感染中皮质类固醇的使用：是敌，还是能成为友？作者回复
Pol Arch Intern Med. 2020 Oct 29;130(10):922-923. doi: 10.20452/pamw.15662.
10
Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?2019冠状病毒病大流行期间的抗TNF治疗：是福是祸？
J Crohns Colitis. 2022 May 10;16(4):517-518. doi: 10.1093/ecco-jcc/jjab167.
引用本文的文献
1
The Estrogen-Autophagy Axis: Insights into Cytoprotection and Therapeutic Potential in Cancer and Infection.雌激素-自噬轴：对癌症和感染中细胞保护及治疗潜力的见解
Int J Mol Sci. 2024 Nov 22;25(23):12576. doi: 10.3390/ijms252312576.
2
Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action.重新利用现有药物治疗新冠病毒病/严重急性呼吸综合征冠状病毒2：药理作用及作用机制综述
Heliyon. 2024 Aug 11;10(16):e35988. doi: 10.1016/j.heliyon.2024.e35988. eCollection 2024 Aug 30.
3
The immune response to COVID-19: Does sex matter?新冠病毒（COVID-19）的免疫反应：性别有影响吗？
Immunology. 2022 Aug;166(4):429-443. doi: 10.1111/imm.13487. Epub 2022 May 3.
Zotero 插件